Meet Eligo, the Startup which Raised €2M to Redefine Antibiotics using CRISPR
Antibiotic resistance is a public health problem worldwide. According to WHO, by 2050, over 10 million…
Antibiotic resistance is a public health problem worldwide. According to WHO, by 2050, over 10 million…
PEP-Therapy and CleveXel Pharma will co-develop targeted therapy in oncology. The product is based on…
CRISPR continues to amass prizes and to consolidate itself as the biggest discovery of the…
Antibiotics abuse is creating a whole new generation of antibiotic-resistant bacteria. As the tolerance to…
As the CRISPR-Cas9 war still goes on, CRISPR Therapeutics closed a Series A and B…
Desktop Genetics has just launched the DeskGen Platform for gene editing. It combines elements of the…
CRISPR Therapeutics appointed Bill Lundberg to Chief Scientific Officer to lead the company’s development programs…
A promising biotechnological approach or an innovative way of avoiding regulation? Large companies spend an…
Gene Therapy is really the hot topic right now in the field of Biotech especially with…
Six years ago, a new sophisticated prokaryotic defense system, was identified in the structure complex…